Insulin degludec, an ultra-long-acting basal insulin, once a day or three times a week versus insulin glargine once a day in patients with type 2 diabetes: a 16-week, randomised, open-label, phase 2 trial (Q42694005)
Jump to navigation
Jump to search
scientific article published on March 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Insulin degludec, an ultra-long-acting basal insulin, once a day or three times a week versus insulin glargine once a day in patients with type 2 diabetes: a 16-week, randomised, open-label, phase 2 trial |
scientific article published on March 2011 |
Statements
1 reference
Insulin degludec, an ultra-long-acting basal insulin, once a day or three times a week versus insulin glargine once a day in patients with type 2 diabetes: a 16-week, randomised, open-label, phase 2 trial (English)
1 reference
Julio Rosenstock
1 reference
Bernard Zinman
1 reference
Chantal Mathieu
1 reference
Greg Fulcher
1 reference
Paturi V Rao
1 reference
Nihal Thomas
1 reference
Lars A Endahl
1 reference
Thue Johansen
1 reference
Rebecka Lindh
1 reference
Andrew Lewin
1 reference
Michel Pinget
1 reference
1 March 2011
1 reference
Identifiers
1 reference